---
title: "美股异动 | 传至少与一家大型制药商进行收购谈判 Moderna 涨超 9%"
description: "周四，Moderna 股价走高，截至发稿，该股涨超 9%，报 26.95 美元。消息面上，一位熟悉讨论情况的人士透露，该公司已与至少一家大型制药商就一项大规模交易进行收购谈判。"
type: "news"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/news/263571808.md"
published_at: "2025-10-30T15:50:04.000Z"
---

# 美股异动 | 传至少与一家大型制药商进行收购谈判 Moderna 涨超 9%

> 周四，Moderna 股价走高，截至发稿，该股涨超 9%，报 26.95 美元。消息面上，一位熟悉讨论情况的人士透露，该公司已与至少一家大型制药商就一项大规模交易进行收购谈判。

智通财经 APP 获悉，周四，Moderna(MRNA.US) 股价走高，截至发稿，该股涨超 9%，报 26.95 美元。消息面上，一位熟悉讨论情况的人士透露，该公司已与至少一家大型制药商就一项大规模交易进行收购谈判。

### Related Stocks

- [MRNA.US - Moderna](https://longbridge.com/zh-CN/quote/MRNA.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| Moderna Signs Five-Year Supply and Manufacturing Agreement with Mexican Government | Moderna Inc. has signed a five-year agreement with the Mexican Government and local partners for the supply of its respi | [Link](https://longbridge.com/zh-CN/news/275453337.md) |
| Mexico enlists Moderna to boost mRNA supply for respiratory diseases | Mexico has entered a long-term agreement with Moderna to enhance its mRNA vaccine supply for respiratory diseases as par | [Link](https://longbridge.com/zh-CN/news/275641500.md) |
| Betting On Moderna? This New Defiance ETF Turns The Volume Up 2X | Defiance ETFs has launched a new 2X leveraged ETF linked to Moderna Inc (NASDAQ:MRNA), named the Defiance Daily Target 2 | [Link](https://longbridge.com/zh-CN/news/275363047.md) |
| Moderna Q4 revenue beats estimates on COVID vaccine sales, influenza vaccine filing accepted | Moderna's Q4 revenue reached $0.7 billion, surpassing analyst expectations, driven mainly by COVID vaccine sales. The co | [Link](https://longbridge.com/zh-CN/news/275897109.md) |
| FDA Flu Ruling Tests Moderna Regulatory Assumptions And mRNA Pipeline Timing | The FDA declined to review Moderna's mRNA flu vaccine application, raising concerns about the company's broader mRNA pip | [Link](https://longbridge.com/zh-CN/news/276009995.md) |

---

> **免责声明**：本文内容仅供参考，不构成任何投资建议。